Literature DB >> 20850742

Systemic fat embolism and the patent foramen ovale--a prospective autopsy study.

Slobodan Nikolić1, Vladimir Zivković, Dragan Babić, Danijela Djonić, Marija Djurić.   

Abstract

A fat embolism is a known and common complication of blunt force injuries, especially pelvic and long bones fractures. The aim of this study was to determine the importance of a patent foramen ovale (PFO) in developing systemic fat embolism (SFE) and eventually fat embolism syndrome (FES) in patients suffering from orthopaedic blunt injuries and consequent lung fat embolism. The sample was divided: 32 subjects with a sealed foramen ovale (SFO), and 20 subjects with a PFO. In our sample, there was no difference in either the incidence of renal fat embolism in subjects with PFO compared to those with SFO (Fisher's exact test 0.228, p=0.154) or in the grade of renal fat embolism (Pearson Chi-square 2.728, p=0.435). However, there was a statistically significant correlation between the grade of lung fat embolism and the number of fractured bones for the whole sample (Spearman's rho 0.271, p=0.052), but no correlation between the grade of lung fat embolism and the ISS or NISS (Pearson correlation 0.048, p=0.736, and 0.108, p=0.445, respectively). In our study, the presence of fat emboli in the kidney, i.e. SFE, could effectively be predicted by the grade of lung fat embolism (the moderate and slight grades of lung fat embolism were better predictors than the massive one: logistic regression - Wald. Coeff.=11.446, p=0.003, Wald. Coeff.=10.553, p=0.001, and Wald. Coeff.=4.128, p=0.042), and less effectively by presence of PFO (Wald. Coeff.=2.850, p=0.091). This study pointed out that lung and SFE are not pure biomechanical events, so the role of a PFO is not crucial in developing a lung fat embolism into a systemic embolism: the fat embolism is more of a biochemical and pathophsyiological event, than a biomechanical one. The appearance of a patent foramen ovale associated with a systemic fat embolism should be less emphasised: maybe arteriovenous shunts and anastomosis between the functional and nutritive, i.e. systemic circulation of lungs play a more important role in developing a SFE than a PFO.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20850742     DOI: 10.1016/j.injury.2010.08.027

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  5 in total

1.  Clinical effectiveness analysis of dextran 40 plus dexamethasone on the prevention of fat embolism syndrome.

Authors:  Xi-Ming Liu; Jin-Cheng Huang; Guo-Dong Wang; Sheng-Hui Lan; Hua-Song Wang; Chang-Wu Pan; Ji-Ping Zhang; Xian-Hua Cai
Journal:  Int J Clin Exp Med       Date:  2014-08-15

2.  Use of the Reamer/Irrigator/Aspirator Decreases Carotid and Cranial Embolic Events in a Canine Model.

Authors:  Anna N Miller; Dwight Deal; James Green; Timothy Houle; William Brown; Clara Thore; David Stump; Lawrence X Webb
Journal:  J Bone Joint Surg Am       Date:  2016-04-20       Impact factor: 5.284

3.  Cerebral fat embolism after traumatic bone fractures: a structured literature review and analysis of published case reports.

Authors:  Luigi Vetrugno; Elena Bignami; Cristian Deana; Flavio Bassi; Maria Vargas; Maria Orsaria; Daniele Bagatto; Cristina Intermite; Francesco Meroi; Francesco Saglietti; Marco Sartori; Daniele Orso; Massimo Robiony; Tiziana Bove
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2021-03-12       Impact factor: 2.953

4.  Intraosseous fluid resuscitation causes systemic fat emboli in a porcine hemorrhagic shock model.

Authors:  Steinar Kristiansen; Benjamin Storm; Dalia Dahle; Terje Domaas Josefsen; Knut Dybwik; Bent Aksel Nilsen; Erik Waage-Nielsen
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2021-12-20       Impact factor: 2.953

5.  Fat embolism syndrome with cerebral fat embolism through a patent foramen ovale: A case report.

Authors:  Lijuan Yang; Jiafang Wu; Baojun Wang
Journal:  Medicine (Baltimore)       Date:  2020-06-12       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.